<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1075"/><api:result><api:object category="publication" id="1075" last-affected-when="2024-04-13T23:41:20.813+01:00" last-modified-when="2024-04-13T23:41:20.813+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1075" created-when="2010-05-17T13:47:30.927+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>false</api:ever-approved><api:reporting-date-1>2000-06-13</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1484388" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1161/01.CIR.101.23.2721" last-modified-when="2022-09-10T11:29:19.47+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;jats:p&gt;
            &lt;jats:italic&gt;Background&lt;/jats:italic&gt;
            —Fetal tachycardia may cause hydrops fetalis and lead to fetal death. No unanimity of opinion exists regarding the optimum treatment. This study evaluates our experience with transplacental sotalol therapy to treat fetal tachycardias in terms of safety and efficacy.
          &lt;/jats:p&gt;
          &lt;jats:p&gt;
            &lt;jats:italic&gt;Methods and Results&lt;/jats:italic&gt;
            —The charts of 21 patients who were treated with sotalol for fetal tachycardia were reviewed. Ten fetuses had atrial flutter (AF), 10 had supraventricular tachycardia (SVT), and 1 had VT. Hydrops fetalis was present in 9 fetuses. Drug treatment was successful in establishing sinus rhythm in 8 of 10 fetuses with AF and in 6 of 10 fetuses with SVT. The mortality rate in this study was 19% (4 of 21 fetuses; 3 had SVT and 1 had AF); 3 deaths occurred just days after the initiation of sotalol therapy, and 1 occurred after a dosage increase. At birth, tachycardia was present in 6 infants. Two patients who converted to sinus rhythm in utero suffered from neurologic pathology postnatally.
          &lt;/jats:p&gt;
          &lt;jats:p&gt;
            &lt;jats:italic&gt;Conclusions&lt;/jats:italic&gt;
            —Fetal tachycardia is a serious condition in which treatment should be initiated, especially in the presence of hydrops fetalis. The high success rate in fetuses with AF suggests that sotalol should be considered a drug of first choice to treat fetal AF. The low conversion rate and the fact that 3 of the 4 deaths in this study occurred in fetuses with SVT indicate that the risks of sotalol therapy outweigh the benefits in this group and that sotalol should, therefore, be limited in the treatment of fetal SVT.
          &lt;/jats:p&gt;</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Oudijk</api:last-name><api:initials>MA</api:initials><api:first-names>Martijn A</api:first-names><api:separate-first-names><api:first-name>Martijn</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Michon</api:last-name><api:initials>MM</api:initials><api:first-names>Maaike M</api:first-names><api:separate-first-names><api:first-name>Maaike</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kleinman</api:last-name><api:initials>CS</api:initials><api:first-names>Charles S</api:first-names><api:separate-first-names><api:first-name>Charles</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kapusta</api:last-name><api:initials>L</api:initials><api:first-names>Livia</api:first-names><api:separate-first-names><api:first-name>Livia</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Stoutenbeek</api:last-name><api:initials>P</api:initials><api:first-names>Philip</api:first-names><api:separate-first-names><api:first-name>Philip</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Visser</api:last-name><api:initials>GHA</api:initials><api:first-names>Gerard HA</api:first-names><api:separate-first-names><api:first-name>Gerard</api:first-name><api:first-name>H</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Meijboom</api:last-name><api:initials>EJ</api:initials><api:first-names>Erik J</api:first-names><api:separate-first-names><api:first-name>Erik</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1161/01.cir.101.23.2721</api:text><api:links><api:link type="doi" href="http://doi.org/10.1161/01.cir.101.23.2721"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1161/01.cir.101.23.2721"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1524-4539</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973719"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0009-7322</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973719"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>23</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Circulation</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2721</api:begin-page><api:end-page>2726</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>13</api:day><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Ovid Technologies (Wolters Kluwer Health)</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1161/01.cir.101.23.2721</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>17</api:day><api:month>3</api:month><api:year>2022</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Sotalol in the Treatment of Fetal Dysrhythmias</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>101</api:text></api:field></api:native></api:record><api:record format="native" id="96475" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0034643869" last-modified-when="2023-12-06T07:30:42.597+00:00"><api:citation-count>155</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Background - Fetal tachycardia may cause hydrops fetalis and lead to fetal death. No unanimity of opinion exists regarding the optimum treatment. This study evaluates our experience with transplacental sotalol therapy to treat fetal tachycardias in terms of safety and efficacy. Methods and Results - The charts of 21 patients who were treated with sotalol for fetal tachycardia were reviewed. Ten fetuses had atrial flutter (AF), 10 had supraventricular tachycardia (SVT), and 1 had VT. Hydrops fetalis was present in 9 fetuses. Drug treatment was successful in establishing sinus rhythm in 8 of 10 fetuses with AF and in 6 of 10 fetuses with SVT. The mortality rate in this study was 19% (4 of 21 fetuses; 3 had SVT and 1 had AF); 3 deaths occurred just days after the initiation of sotalol therapy, and I occurred after a dosage increase. At birth, tachycardia was present in 6 infants. Two patients who converted to sinus rhythm in utero suffered from neurologic pathology postnatally. Conclusions - Fetal tachycardia is a serious condition in which treatment should be initiated, especially in the presence of hydrops fetalis. The high success rate in fetuses with AF suggests that sotalol should be considered a drug of first choice to treat fetal AF. The low conversion rate and the fact that 3 of the 4 deaths in this study occurred in fetuses with SVT indicate that the risks of sotalol therapy outweigh the benefits in this group and that sotalol should, therefore, be limited in the treatment of fetal SVT.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Oudijk</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">University Medical Center Utrecht</api:line><api:line type="city">Utrecht</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6602215258</api:identifier></api:identifiers></api:person><api:person><api:last-name>Michon</api:last-name><api:initials>MM</api:initials><api:first-names>MM</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">University Medical Center Utrecht</api:line><api:line type="city">Utrecht</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6602196347</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kleinman</api:last-name><api:initials>CS</api:initials><api:first-names>CS</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>S</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="US"><api:line type="organisation">Yale School of Medicine</api:line><api:line type="city">New Haven</api:line><api:line type="country">United States</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005554417</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kapusta</api:last-name><api:initials>L</api:initials><api:first-names>L</api:first-names><api:separate-first-names><api:first-name>L</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">Radboud University Medical Center</api:line><api:line type="city">Nijmegen</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">24457520900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Stoutenbeek</api:last-name><api:initials>P</api:initials><api:first-names>P</api:first-names><api:separate-first-names><api:first-name>P</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">University Medical Center Utrecht</api:line><api:line type="city">Utrecht</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35554788400</api:identifier></api:identifiers></api:person><api:person><api:last-name>Visser</api:last-name><api:initials>GHA</api:initials><api:first-names>GHA</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>H</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">University Medical Center Utrecht</api:line><api:line type="city">Utrecht</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35493894800</api:identifier></api:identifiers></api:person><api:person><api:last-name>Meijboom</api:last-name><api:initials>EJ</api:initials><api:first-names>EJ</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">University Medical Center Utrecht</api:line><api:line type="city">Utrecht</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005833781</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1161/01.CIR.101.23.2721</api:text><api:links><api:link type="doi" href="http://doi.org/10.1161/01.CIR.101.23.2721"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1161/01.CIR.101.23.2721"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10851210</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0009-7322</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973719"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>23</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Circulation</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2721</api:begin-page><api:end-page>2726</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>13</api:day><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Sotalol in the treatment of fetal dysrhythmias</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>101</api:text></api:field></api:native></api:record><api:record format="native" id="1075" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10851210" last-modified-when="2020-04-29T04:28:19.393+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>BACKGROUND: Fetal tachycardia may cause hydrops fetalis and lead to fetal death. No unanimity of opinion exists regarding the optimum treatment. This study evaluates our experience with transplacental sotalol therapy to treat fetal tachycardias in terms of safety and efficacy. METHODS AND RESULTS: The charts of 21 patients who were treated with sotalol for fetal tachycardia were reviewed. Ten fetuses had atrial flutter (AF), 10 had supraventricular tachycardia (SVT), and 1 had VT. Hydrops fetalis was present in 9 fetuses. Drug treatment was successful in establishing sinus rhythm in 8 of 10 fetuses with AF and in 6 of 10 fetuses with SVT. The mortality rate in this study was 19% (4 of 21 fetuses; 3 had SVT and 1 had AF); 3 deaths occurred just days after the initiation of sotalol therapy, and 1 occurred after a dosage increase. At birth, tachycardia was present in 6 infants. Two patients who converted to sinus rhythm in utero suffered from neurologic pathology postnatally. CONCLUSIONS: Fetal tachycardia is a serious condition in which treatment should be initiated, especially in the presence of hydrops fetalis. The high success rate in fetuses with AF suggests that sotalol should be considered a drug of first choice to treat fetal AF. The low conversion rate and the fact that 3 of the 4 deaths in this study occurred in fetuses with SVT indicate that the risks of sotalol therapy outweigh the benefits in this group and that sotalol should, therefore, be limited in the treatment of fetal SVT.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Oudijk</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="full">Department of Obstetrics, University Medical Center, Utrecht, the Netherlands.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Michon</api:last-name><api:initials>MM</api:initials><api:first-names>MM</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kleinman</api:last-name><api:initials>CS</api:initials><api:first-names>CS</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kapusta</api:last-name><api:initials>L</api:initials><api:first-names>L</api:first-names><api:separate-first-names><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Stoutenbeek</api:last-name><api:initials>P</api:initials><api:first-names>P</api:first-names><api:separate-first-names><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Visser</api:last-name><api:initials>GH</api:initials><api:first-names>GH</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>H</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Meijboom</api:last-name><api:initials>EJ</api:initials><api:first-names>EJ</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10851210</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1161/01.cir.101.23.2721</api:text><api:links><api:link type="doi" href="http://doi.org/10.1161/01.cir.101.23.2721"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1161/01.cir.101.23.2721"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1524-4539</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973719"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>23</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Circulation</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Anti-Arrhythmia Agents</api:keyword><api:keyword scheme="mesh">Atrial Fibrillation</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Follow-Up Studies</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Hydrops Fetalis</api:keyword><api:keyword scheme="mesh">Infant, Newborn</api:keyword><api:keyword scheme="mesh">Maternal-Fetal Exchange</api:keyword><api:keyword scheme="mesh">Morbidity</api:keyword><api:keyword scheme="mesh">Pregnancy</api:keyword><api:keyword scheme="mesh">Recurrence</api:keyword><api:keyword scheme="mesh">Retrospective Studies</api:keyword><api:keyword scheme="mesh">Sotalol</api:keyword><api:keyword scheme="mesh">Tachycardia, Supraventricular</api:keyword><api:keyword scheme="mesh">Treatment Outcome</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>United States</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2721</api:begin-page><api:end-page>2726</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>13</api:day><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>29</api:day><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Sotalol in the treatment of fetal dysrhythmias.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Multicenter Study</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>101</api:text></api:field></api:native></api:record><api:record format="native" id="882217" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10851210" last-modified-when="2023-01-31T17:46:53.637+00:00"><api:citation-count>66</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;h4&gt;Background&lt;/h4&gt;Fetal tachycardia may cause hydrops fetalis and lead to fetal death. No unanimity of opinion exists regarding the optimum treatment. This study evaluates our experience with transplacental sotalol therapy to treat fetal tachycardias in terms of safety and efficacy.&lt;h4&gt;Methods and results&lt;/h4&gt;The charts of 21 patients who were treated with sotalol for fetal tachycardia were reviewed. Ten fetuses had atrial flutter (AF), 10 had supraventricular tachycardia (SVT), and 1 had VT. Hydrops fetalis was present in 9 fetuses. Drug treatment was successful in establishing sinus rhythm in 8 of 10 fetuses with AF and in 6 of 10 fetuses with SVT. The mortality rate in this study was 19% (4 of 21 fetuses; 3 had SVT and 1 had AF); 3 deaths occurred just days after the initiation of sotalol therapy, and 1 occurred after a dosage increase. At birth, tachycardia was present in 6 infants. Two patients who converted to sinus rhythm in utero suffered from neurologic pathology postnatally.&lt;h4&gt;Conclusions&lt;/h4&gt;Fetal tachycardia is a serious condition in which treatment should be initiated, especially in the presence of hydrops fetalis. The high success rate in fetuses with AF suggests that sotalol should be considered a drug of first choice to treat fetal AF. The low conversion rate and the fact that 3 of the 4 deaths in this study occurred in fetuses with SVT indicate that the risks of sotalol therapy outweigh the benefits in this group and that sotalol should, therefore, be limited in the treatment of fetal SVT.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="NL"><api:line type="full">Department of Obstetrics, University Medical Center, Utrecht, the Netherlands.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Oudijk</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0001-8672-4365</api:identifier></api:identifiers></api:person><api:person><api:last-name>Michon</api:last-name><api:initials>MM</api:initials><api:first-names>MM</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kleinman</api:last-name><api:initials>CS</api:initials><api:first-names>CS</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kapusta</api:last-name><api:initials>L</api:initials><api:first-names>L</api:first-names><api:separate-first-names><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Stoutenbeek</api:last-name><api:initials>P</api:initials><api:first-names>P</api:first-names><api:separate-first-names><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Visser</api:last-name><api:initials>GH</api:initials><api:first-names>GH</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>H</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Meijboom</api:last-name><api:initials>EJ</api:initials><api:first-names>EJ</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1161/01.cir.101.23.2721</api:text><api:links><api:link type="doi" href="http://doi.org/10.1161/01.cir.101.23.2721"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1161/01.cir.101.23.2721"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1524-4539</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973719"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10851210</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0009-7322</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973719"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>23</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Circulation</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Hydrops Fetalis</api:keyword><api:keyword scheme="mesh">Atrial Fibrillation</api:keyword><api:keyword scheme="mesh">Tachycardia, Supraventricular</api:keyword><api:keyword scheme="mesh">Recurrence</api:keyword><api:keyword scheme="mesh">Sotalol</api:keyword><api:keyword scheme="mesh">Anti-Arrhythmia Agents</api:keyword><api:keyword scheme="mesh">Treatment Outcome</api:keyword><api:keyword scheme="mesh">Morbidity</api:keyword><api:keyword scheme="mesh">Retrospective Studies</api:keyword><api:keyword scheme="mesh">Follow-Up Studies</api:keyword><api:keyword scheme="mesh">Pregnancy</api:keyword><api:keyword scheme="mesh">Maternal-Fetal Exchange</api:keyword><api:keyword scheme="mesh">Infant, Newborn</api:keyword><api:keyword scheme="mesh">Female</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2721</api:begin-page><api:end-page>2726</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>14</api:day><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Sotalol in the treatment of fetal dysrhythmias.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Multicenter Study</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>101</api:text></api:field></api:native></api:record><api:record format="native" id="2826143" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1043044344" last-modified-when="2024-04-13T23:41:20.82+01:00"><api:citation-count>135</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Oudijk</api:last-name><api:initials>MA</api:initials><api:first-names>Martijn A</api:first-names><api:separate-first-names><api:first-name>Martijn</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">University Medical Center Utrecht</api:line><api:line type="city">Utrecht</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0754435127.21</api:identifier></api:identifiers></api:person><api:person><api:last-name>Michon</api:last-name><api:initials>MM</api:initials><api:first-names>Maaike M</api:first-names><api:separate-first-names><api:first-name>Maaike</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">University Medical Center Utrecht</api:line><api:line type="city">Utrecht</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01210506741.74</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kleinman</api:last-name><api:initials>CS</api:initials><api:first-names>Charles S</api:first-names><api:separate-first-names><api:first-name>Charles</api:first-name><api:first-name>S</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">University Medical Center Utrecht</api:line><api:line type="city">Utrecht</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0612625733.81</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kapusta</api:last-name><api:initials>L</api:initials><api:first-names>Livia</api:first-names><api:separate-first-names><api:first-name>Livia</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">University Medical Center Utrecht</api:line><api:line type="city">Utrecht</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01337433511.85</api:identifier></api:identifiers></api:person><api:person><api:last-name>Stoutenbeek</api:last-name><api:initials>P</api:initials><api:first-names>Philip</api:first-names><api:separate-first-names><api:first-name>Philip</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">University Medical Center Utrecht</api:line><api:line type="city">Utrecht</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.014460166054.29</api:identifier></api:identifiers></api:person><api:person><api:last-name>Visser</api:last-name><api:initials>GHA</api:initials><api:first-names>Gerard HA</api:first-names><api:separate-first-names><api:first-name>Gerard</api:first-name><api:first-name>H</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">University Medical Center Utrecht</api:line><api:line type="city">Utrecht</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.011472271337.77</api:identifier></api:identifiers></api:person><api:person><api:last-name>Meijboom</api:last-name><api:initials>EJ</api:initials><api:first-names>Erik J</api:first-names><api:separate-first-names><api:first-name>Erik</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="NL"><api:line type="organisation">University Medical Center Utrecht</api:line><api:line type="city">Utrecht</api:line><api:line type="country">Netherlands</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01062031177.24</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1161/01.cir.101.23.2721</api:text><api:links><api:link type="doi" href="http://doi.org/10.1161/01.cir.101.23.2721"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1161/01.cir.101.23.2721"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10851210</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>19.95</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0009-7322</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973719"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>23</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Circulation</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">3215 Reproductive Medicine</api:keyword><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="rcdc">Pediatric</api:keyword><api:keyword scheme="rcdc">Perinatal Period - Conditions Originating in Perinatal Period</api:keyword><api:keyword scheme="rcdc">Heart Disease</api:keyword><api:keyword scheme="rcdc">Patient Safety</api:keyword><api:keyword scheme="rcdc">Cardiovascular</api:keyword><api:keyword scheme="hrcs-rac">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-rac">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="sdg">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh">Anti-Arrhythmia Agents</api:keyword><api:keyword scheme="mesh">Atrial Fibrillation</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Follow-Up Studies</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Hydrops Fetalis</api:keyword><api:keyword scheme="mesh">Infant, Newborn</api:keyword><api:keyword scheme="mesh">Maternal-Fetal Exchange</api:keyword><api:keyword scheme="mesh">Morbidity</api:keyword><api:keyword scheme="mesh">Pregnancy</api:keyword><api:keyword scheme="mesh">Recurrence</api:keyword><api:keyword scheme="mesh">Retrospective Studies</api:keyword><api:keyword scheme="mesh">Sotalol</api:keyword><api:keyword scheme="mesh">Tachycardia, Supraventricular</api:keyword><api:keyword scheme="mesh">Treatment Outcome</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Bronze OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2721</api:begin-page><api:end-page>2726</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>13</api:day><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wolters Kluwer</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>3</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Sotalol in the Treatment of Fetal Dysrhythmias</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>101</api:text></api:field></api:native></api:record><api:record format="native" id="241712" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000087571900021" last-modified-when="2024-03-14T05:45:33.257+00:00"><api:citation-count>94</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Oudijk</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="researcherid">C-1520-2019</api:identifier></api:identifiers></api:person><api:person><api:last-name>Michon</api:last-name><api:initials>MM</api:initials><api:first-names>MM</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kleinman</api:last-name><api:initials>CS</api:initials><api:first-names>CS</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kapusta</api:last-name><api:initials>L</api:initials><api:first-names>L</api:first-names><api:separate-first-names><api:first-name>L</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="researcherid">L-4426-2015</api:identifier></api:identifiers></api:person><api:person><api:last-name>Stoutenbeek</api:last-name><api:initials>P</api:initials><api:first-names>P</api:first-names><api:separate-first-names><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Visser</api:last-name><api:initials>GHA</api:initials><api:first-names>GHA</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>H</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Meijboom</api:last-name><api:initials>EJ</api:initials><api:first-names>EJ</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000087571900021&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1161/01.CIR.101.23.2721</api:text><api:links><api:link type="doi" href="http://doi.org/10.1161/01.CIR.101.23.2721"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1161/01.CIR.101.23.2721"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">323NM</api:identifier><api:identifier scheme="pubmed">10851210</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0009-7322</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973719"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>23</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>CIRCULATION</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>tachycardia</api:keyword><api:keyword>arrhythmia</api:keyword><api:keyword>maternal-fetal exchange</api:keyword><api:keyword>sotalol</api:keyword><api:keyword>hydrops fetalis</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2721</api:begin-page><api:end-page>2726</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Sotalol in the treatment of fetal dysrhythmias</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>101</api:text></api:field></api:native></api:record><api:record format="native" id="24795" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000087571900021" last-modified-when="2014-07-25T11:07:19.877+01:00"><api:citation-count>37</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Oudijk</api:last-name><api:initials>MA</api:initials><api:first-names>MA</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Michon</api:last-name><api:initials>MM</api:initials><api:first-names>MM</api:first-names><api:separate-first-names><api:first-name>M</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kleinman</api:last-name><api:initials>CS</api:initials><api:first-names>CS</api:first-names><api:separate-first-names><api:first-name>C</api:first-name><api:first-name>S</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kapusta</api:last-name><api:initials>L</api:initials><api:first-names>L</api:first-names><api:separate-first-names><api:first-name>L</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Stoutenbeek</api:last-name><api:initials>P</api:initials><api:first-names>P</api:first-names><api:separate-first-names><api:first-name>P</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Visser</api:last-name><api:initials>GHA</api:initials><api:first-names>GHA</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>H</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Meijboom</api:last-name><api:initials>EJ</api:initials><api:first-names>EJ</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0009-7322</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973719"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>23</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>CIRCULATION</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>tachycardia</api:keyword><api:keyword>arrhythmia</api:keyword><api:keyword>maternal-fetal exchange</api:keyword><api:keyword>sotalol</api:keyword><api:keyword>hydrops fetalis</api:keyword><api:keyword>SUPRAVENTRICULAR TACHYCARDIA</api:keyword><api:keyword>ORAL SOTALOL</api:keyword><api:keyword>MANAGEMENT</api:keyword><api:keyword>TACHYARRHYTHMIAS</api:keyword><api:keyword>ARRHYTHMIAS</api:keyword><api:keyword>DIGOXIN</api:keyword><api:keyword>FLECAINIDE</api:keyword><api:keyword>DIAGNOSIS</api:keyword><api:keyword>EFFICACY</api:keyword><api:keyword>ECHOCARDIOGRAPHY</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>2721</api:begin-page><api:end-page>2726</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>13</api:day><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Sotalol in the treatment of fetal dysrhythmias</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>101</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Anti-Arrhythmia Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Atrial Fibrillation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Follow-Up Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Hydrops Fetalis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Infant, Newborn</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Maternal-Fetal Exchange</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Morbidity</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Pregnancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Recurrence</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Retrospective Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Sotalol</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tachycardia, Supraventricular</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Treatment Outcome</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Hydrops Fetalis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Atrial Fibrillation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tachycardia, Supraventricular</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Recurrence</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Sotalol</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Anti-Arrhythmia Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Treatment Outcome</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Morbidity</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Retrospective Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Follow-Up Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Pregnancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Maternal-Fetal Exchange</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Infant, Newborn</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3215 Reproductive Medicine</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Pediatric</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Perinatal Period - Conditions Originating in Perinatal Period</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Heart Disease</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Patient Safety</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cardiovascular</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="sdg" origin="record-data" source="dimensions">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Anti-Arrhythmia Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Atrial Fibrillation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Follow-Up Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Hydrops Fetalis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Infant, Newborn</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Maternal-Fetal Exchange</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Morbidity</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Pregnancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Recurrence</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Retrospective Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Sotalol</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tachycardia, Supraventricular</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Treatment Outcome</api:keyword><api:keyword origin="record-data" source="wos-lite">tachycardia</api:keyword><api:keyword origin="record-data" source="wos-lite">arrhythmia</api:keyword><api:keyword origin="record-data" source="wos-lite">maternal-fetal exchange</api:keyword><api:keyword origin="record-data" source="wos-lite">sotalol</api:keyword><api:keyword origin="record-data" source="wos-lite">hydrops fetalis</api:keyword><api:keyword origin="record-data" source="wos">tachycardia</api:keyword><api:keyword origin="record-data" source="wos">arrhythmia</api:keyword><api:keyword origin="record-data" source="wos">maternal-fetal exchange</api:keyword><api:keyword origin="record-data" source="wos">sotalol</api:keyword><api:keyword origin="record-data" source="wos">hydrops fetalis</api:keyword><api:keyword origin="record-data" source="wos">SUPRAVENTRICULAR TACHYCARDIA</api:keyword><api:keyword origin="record-data" source="wos">ORAL SOTALOL</api:keyword><api:keyword origin="record-data" source="wos">MANAGEMENT</api:keyword><api:keyword origin="record-data" source="wos">TACHYARRHYTHMIAS</api:keyword><api:keyword origin="record-data" source="wos">ARRHYTHMIAS</api:keyword><api:keyword origin="record-data" source="wos">DIGOXIN</api:keyword><api:keyword origin="record-data" source="wos">FLECAINIDE</api:keyword><api:keyword origin="record-data" source="wos">DIAGNOSIS</api:keyword><api:keyword origin="record-data" source="wos">EFFICACY</api:keyword><api:keyword origin="record-data" source="wos">ECHOCARDIOGRAPHY</api:keyword><api:keyword scheme="for" origin="issn-inferred">1102 Cardiorespiratory Medicine and Haematology</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">1117 Public Health and Health Services</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Cardiovascular System &amp; Hematology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3201 Cardiovascular medicine and haematology</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3202 Clinical sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">4207 Sports science and exercise</api:keyword></api:keywords></api:all-labels><api:journal issn="0009-7322" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973719" title="Circulation"><api:records><api:record source-name="summary"><api:title>Circulation</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1075/relationships"/></api:object></api:result></api:response>